xanthinol niacinate has been researched along with pentoxifylline in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (80.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Jakobs, P; Martin, G | 1 |
| Zicot, M | 1 |
| Hutten, H; Reichl, R; Vaupel, P | 1 |
| Cartheuser, C; Komarek, J | 1 |
| Akhaladze, GG; Aref'ev, AE; Gal'perin, EI; Nasirov, FN; Sakevarashvili, GR; Tatishvili, GG | 1 |
| Lupal'tsev, VI | 1 |
| El'skaia, IE; Neugodov, IuV; Popov, VV; Sokolov, GF | 1 |
| Gómez Reyes, D; Rojas Hidalgo, E | 2 |
| Pivovarova, EIa; Samsonov, AA; Vorob'ev, LP | 1 |
| Berdichevskiĭ, MIa; Dronnikova, IS; Onopchenko, NV | 1 |
| Nuzov, BG | 1 |
| Eichhorn, T; Martin, G | 1 |
| Benignetti, G; Benvenuti, C; Fabbri, F | 1 |
| Kasabian, IN; Kukes, VG; Mamaeva, GG; Spesivtseva, VG | 1 |
| Fossati, C | 1 |
| Janaki, S | 1 |
| Korjev, MO; Kucherov, II; Mistryukova, LO; Podol'skaya, IA; Rytik, PG | 1 |
| Chernikov, VP; Golosnitskiĭ, PIu; Koshkin, VM; Kosykh, IV; Kuznetsov, MR; Lisenkov, OP; Ostapchuk, NA; Rodionov, SV; Tepliakov, SA; Virganskiĭ, AO | 1 |
3 review(s) available for xanthinol niacinate and pentoxifylline
| Article | Year |
|---|---|
[is there a treatment for peripheral arterial insufficiency?].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clofibrate; Dipyridamole; Fibrinolytic Agents; Humans; Pentoxifylline; Snake Venoms; Xanthinol Niacinate | 1979 |
[Therapy of diabetic angiopathies].
Topics: Acetylcholine; Adrenal Cortex Hormones; Anti-Bacterial Agents; Diabetic Angiopathies; Fibrinolytic Agents; Heparin; Humans; Pentoxifylline; Vasodilator Agents; Xanthinol Niacinate | 1981 |
Novel inhibitors of HIV discovered among existing classes of pharmaceutical compounds indicated for unrelated clinical indications.
Topics: Animals; Anti-HIV Agents; Drug Combinations; Ferrous Compounds; HIV Infections; Humans; Mucins; Pentoxifylline; Vasodilator Agents; Xanthinol Niacinate | 2009 |
4 trial(s) available for xanthinol niacinate and pentoxifylline
| Article | Year |
|---|---|
[The therapy of tinnitus resulting from blast injury (author's transl)].
Topics: Adolescent; Adult; Betahistine; Blast Injuries; Clinical Trials as Topic; Drug Evaluation; Female; Germany, West; Humans; Male; Middle Aged; Pentoxifylline; Prospective Studies; Tinnitus; Xanthinol Niacinate | 1978 |
[Teonicol and trental in the treatment of duodenal ulcer].
Topics: Adolescent; Adult; Anti-Ulcer Agents; Clinical Trials as Topic; Duodenal Ulcer; Humans; Middle Aged; Pentoxifylline; Theobromine; Theophylline; Xanthinol Niacinate | 1986 |
[Use of trental and complamine in the microcirculatory disorders of diabetes mellitus].
Topics: Adult; Aged; Blood; Clinical Trials as Topic; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypoglycemic Agents; Male; Microcirculation; Middle Aged; Pentoxifylline; Theobromine; Theophylline; Xanthinol Niacinate | 1980 |
Pentoxifylline in strokes: a clinical study.
Topics: Adult; Blood Pressure; Drug Evaluation; Female; Hemiplegia; Humans; Intelligence; Intracranial Embolism and Thrombosis; Male; Memory Disorders; Pentoxifylline; Pulse; Random Allocation; Speech Disorders; Theobromine; Xanthinol Niacinate | 1980 |
13 other study(ies) available for xanthinol niacinate and pentoxifylline
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Influence of various vasodilatory drugs on the cerebral circulation in rabbits and rats.
Topics: Animals; Bencyclane; Carotid Artery, Internal; Cerebrovascular Circulation; Cinnarizine; Injections, Intra-Arterial; Nafronyl; Papaverine; Pentoxifylline; Piribedil; Rabbits; Rats; Vascular Resistance; Vasodilator Agents; Vincamine; Xanthinol Niacinate | 1979 |
[Effect of pentoxifylline, xanthinol nicotinate and theophylline on the cardiovascular system, myocardial dynamics and left ventricular contractility of the dog in short-system, experiments].
Topics: Animals; Dogs; Hemodynamics; Myocardial Contraction; Myocardium; Oxygen Consumption; Pentoxifylline; Theobromine; Theophylline; Time Factors; Xanthinol Niacinate | 1977 |
[Disorders of organic hemodynamics of the liver and their correction in suppurative cholangitis].
Topics: Acute Disease; Animals; Aprotinin; Ascorbic Acid; Aspirin; Cholangitis; Cholestasis; Dextrans; Dipyridamole; Drainage; Drug Combinations; Heparin; Humans; Liver Circulation; Male; Microcirculation; Pentoxifylline; Pyridinolcarbamate; Rats; Rutin; Suppuration; Ultrasonography; Xanthinol Niacinate | 1991 |
[Use of a combination of rheopolyglucin, complamin and trental in the complex treatment of acute postoperative pancreatitis].
Topics: Acute Disease; Dextrans; Drug Therapy, Combination; Humans; Pancreatitis; Pentoxifylline; Platelet Aggregation Inhibitors; Postoperative Complications; Theobromine; Theophylline; Xanthinol Niacinate | 1988 |
[The onset of circulatory venous gangrene of the arm and its successful treatment by thrombolysis].
Topics: Adult; Arm; Drug Therapy, Combination; Female; Fibrinolytic Agents; Gangrene; Heparin; Humans; Infusions, Intravenous; Pentoxifylline; Subclavian Vein; Theobromine; Theophylline; Thrombolytic Therapy; Thrombosis; Xanthinol Niacinate | 1989 |
[Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
Topics: Adult; Aged; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Intermittent Claudication; Male; Middle Aged; Pentoxifylline; Theobromine; Theophylline; Xanthinol Niacinate | 1988 |
[Effect of a series of vasoactive drugs on the compensatory adaptive processes of the brain during acute experimental cerebral venous stasis].
Topics: Adaptation, Physiological; Aminophylline; Animals; Brain; Cerebrovascular Disorders; Hydroxyethylrutoside; Pentoxifylline; Rats; Vasodilator Agents; Vinca Alkaloids; Xanthinol Niacinate | 1987 |
[Xanthinic derivatives in the treatment of intermittent claudication syndrome in diabetic patients].
Topics: Diabetes Complications; Diabetic Angiopathies; Drug Therapy, Combination; Humans; Intermittent Claudication; Pentoxifylline; Theophylline; Xanthinol Niacinate | 1986 |
[Use of teonikol and trental in the combined treatment of patients with suppurative surgical infection and concomitant diabetes mellitus].
Topics: Chronic Disease; Conjunctiva; Diabetes Mellitus; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; Middle Aged; Pentoxifylline; Plethysmography, Impedance; Surgical Wound Infection; Theobromine; Theophylline; Time Factors; Xanthinol Niacinate | 1985 |
[Course and prognosis in sudden deafness].
Topics: Audiometry, Pure-Tone; Auditory Threshold; Cochlea; Dextrans; Drug Therapy, Combination; Female; Follow-Up Studies; Hearing Loss, Sudden; Humans; Male; Microcirculation; Middle Aged; Pentoxifylline; Risk; Saline Solution, Hypertonic; Xanthinol Niacinate | 1984 |
[Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Female; Humans; Male; Middle Aged; Pentoxifylline; Theobromine; Theophylline; Xanthinol Niacinate | 1983 |
[Role of low-dose acetylsalicylic acid in comprehensive postoperative treatment of patients with lower-limb chronic arterial insufficiency].
Topics: Aspirin; Blood Coagulation; Blood Viscosity; Femoral Artery; Graft Occlusion, Vascular; Humans; Lower Extremity; Male; Pentoxifylline; Peripheral Arterial Disease; Platelet Aggregation; Platelet Aggregation Inhibitors; Popliteal Artery; Postoperative Period; Reoperation; Treatment Outcome; Vascular Grafting; Vascular Patency; Vasodilator Agents; Xanthinol Niacinate | 2011 |